Healthcare AI agents: which startup is ahead?

Which healthcare AI agent startups are serious contenders today?

Eight healthcare AI agent startups currently deserve a place in this comparison, and the real competitive field is narrower than the funding headlines suggest.

We include companies whose agents complete healthcare work: they conduct conversations, interpret documents, apply clinical or administrative rules, update health systems, coordinate follow-ups and escalate difficult cases. A chatbot that answers basic questions does not meet that bar.

The comparison covers Hippocratic AI, Assort Health, Qventus, Tennr, Infinitus Systems, Notable, Hyro and Anterior. These companies compete across patient engagement, scheduling, referrals, hospital operations, payer reviews and administrative calls.

We exclude Abridge, Ambience Healthcare and Nabla because clinical documentation remains their main product. Aidoc and PathAI belong in diagnostics. OpenEvidence mainly helps clinicians retrieve medical information. General-purpose agent builders also sit outside the scope because healthcare is only one of many markets they serve.

Funding gives us a useful starting point, although it says little about whether an agent works reliably inside a hospital. Hippocratic AI has raised the most, followed by Assort Health and Qventus. At the other end, Anterior has built a serious payer business with only $64 million.

Startup	Main healthcare AI agent focus	Cumulative funding	Latest major funding disclosure
Hippocratic AI	Patient-facing agents for care management, outreach, intake and life sciences	$404M	$126M Series C at a $3.5B valuation
Assort Health	Scheduling, intake, referrals, refills, eligibility, payments and patient outreach	More than $222M	$120M Series C at a $1.2B valuation
Qventus	Hospital operations, surgical capacity, patient flow and care-gap automation	About $198M	$105M Series D, following $93M previously raised
Tennr	Referral intake, payer requirements, benefits checks and patient orchestration	About $162M	$101M Series C
Notable	Patient access, prior authorization, revenue cycle and care operations	About $119M	$100M Series B
Infinitus Systems	Voice agents for benefits, prior authorization and healthcare calls	$102.9M	$51.5M Series C
Hyro	Voice and digital agents for health-system patient access	$95M	$45M strategic growth round
Anterior	Clinical-review agents for health plans	$64M	$40M funding round

Is Hippocratic AI already the clear leader in healthcare AI agents?

Hippocratic AI leads healthcare AI agents today, although Assort Health has made the race much closer during the past year.

Hippocratic has the broadest platform in the field. Its catalogue now contains more than 1,000 agent configurations covering providers, payers and pharmaceutical companies. The agents handle post-discharge support, chronic-care outreach, medication reviews, screenings, intake, appointment scheduling and clinical-trial communication. More than 60 organizations use the platform.

Assort is narrower, but its position in patient access has strengthened quickly. The company has expanded from specialty appointment scheduling into referrals, intake forms, medication refills, eligibility checks, lab requests, payments and outbound campaigns. Its latest funding announcement says revenue grew twentyfold in 15 months.

We would place Hippocratic at 100 and Assort around 85 today. Hippocratic’s lead comes from its clinical breadth, safety work and range of customers. Assort is already close on commercial momentum and disclosed interaction volume.

A clear gap opens after those two. Qventus has a deeper record inside hospital operations, Tennr is strong in referrals, and Anterior is emerging in payer reviews. Each could dominate its own workflow without becoming the overall healthcare agent leader.

If you want more recent data on this point, please see our latest healthcare AI market report.

Who has the biggest healthcare AI agent deployment?

Hippocratic AI has the strongest disclosed clinical deployment, while Assort Health is almost level on patient-access volume.

Hippocratic says its agents have completed more than 200 million patient interactions. A separate technical disclosure gives us a cleaner production benchmark: more than 10 million real patient calls. An “interaction” can mean a conversational turn, a test or another smaller unit of activity. The real-call figure still puts Hippocratic far beyond a typical pilot.

Assort reports more than 190 million patient interactions across 22 specialties, 62,000 care protocols and 1.6 million decision pathways. The platform serves more than 5,000 providers across hundreds of healthcare organizations. Assort’s numbers cover patient-access work, including scheduling, triage, referrals and follow-up, so they should not be compared one-for-one with Hippocratic’s clinical conversations.

Other startups show meaningful production use at a smaller disclosed scale. Infinitus says its agents supported 1.17 million patients during 2025 and have handled more than 100 million minutes of conversations. Tennr now powers millions of care pathways each month. Hyro reaches patients across dozens of health systems, although it no longer presents one simple volume figure that can be compared cleanly with the leaders.

Hippocratic leads on clinically oriented agent use, while Assort has built a similarly large footprint around the healthcare front door.

Which healthcare AI agent startup is building the strongest business?

Assort Health currently has the best commercial growth story in healthcare AI agents.

Assort’s twentyfold revenue increase over 15 months is the strongest disclosed growth figure in the field. The company had already reported eightfold growth from late 2024 before raising additional rounds, which suggests a continuing trajectory rather than one unusually favorable quarter. Its funding increased from $26 million to more than $222 million in roughly 14 months as investors followed the commercial expansion.

The customer results explain where the growth is coming from. Michigan Orthopedic Surgeons reported $2.3 million in additional revenue and 5% more appointments after deploying Assort. SENTA reported $1.3 million in recovered appointment revenue, a 97% reduction in hold time and more than 250 staff hours saved each month. Chesapeake Health Care attributed more than $1 million in after-hours revenue to the platform.

Tennr has the next strongest growth case. Its revenue more than tripled across two quarters before its Series C, and its current customer evidence covers referral growth, faster processing and lower staffing needs. One customer processed 157% more referrals, removed a daily backlog and tripled its business without increasing headcount.

Hippocratic could already have more revenue than either company, but it has not published a comparable revenue or annual recurring revenue figure. Qventus is an older enterprise business with major hospital contracts, yet its recent financial growth remains private.

Assort leads on proven commercial acceleration. We cannot say with confidence that it leads on absolute revenue.

If you want more recent data on this point, please see our latest healthcare AI market report.

Whose healthcare AI agents are mature enough for real clinical work?

Hippocratic AI has the most mature patient-facing clinical agent platform, while Qventus has the deepest record inside hospital operations.

Hippocratic has moved well beyond scripted appointment reminders. Its agents discuss medication adherence, monitor recovery after discharge, collect medical histories, support chronic-care programs and recognize situations that require a nurse. The company deliberately limits its scope: its agents do not diagnose or prescribe, and higher-risk conversations are routed to humans.

Polaris 5.0 added more than 20 clinical skills covering areas such as lab interpretation, drug safety, insurance benefits and medical intake. Hippocratic also benchmarked the model across more than 50 clinical, regulatory and conversational tests. The benchmarks were designed by the company, so they deserve some caution, but few competitors disclose testing across so many different healthcare tasks.

Qventus solves a different problem. Its agents work across operating-room schedules, inpatient capacity, discharge planning, coding and care gaps. Those deployments require reliable EHR integration, knowledge of local hospital rules and cooperation from nurses, physicians and operations teams. Boston Medical Center’s latest case study reported 25,400 staff hours saved through capacity automation.

Assort and Tennr are already mature within their narrower workflows. Assort can apply provider-specific scheduling rules and write appointments back into the EHR. Tennr reads faxes and clinical documents, checks coverage requirements, requests missing information and moves referrals through the next step.

Anterior also works in production, though its autonomy stays carefully bounded. The agent recommends approval or sends the case to a human reviewer. It never autonomously denies care.

Who has the strongest proof that healthcare AI agents are safe?

Hippocratic AI leads on testing scale, while Anterior has the cleanest independent accuracy evidence.

Hippocratic reports a 99.9% safety score across more than 10 million real patient calls. Its agents have also been tested through hundreds of thousands of simulated calls and reviews involving thousands of licensed clinicians. Patients gave the system an average rating of 8.95 out of 10.

Those numbers are unusually large for a healthcare voice product. The main limitation is independence. Hippocratic designed the platform, selected the tests and participated in the research. We view the results as serious evidence of internal safety engineering rather than a final external verdict.

Anterior’s evidence covers a narrower job, yet the validation is stronger. KLAS Research verified 99.24% clinical accuracy and a 74% reduction in time spent on manual clinical reviews. Anterior also published a bias evaluation based on 7,166 human-reviewed cases, although several demographic groups remained too small for firm conclusions.

Assort reports more than 95% scheduling accuracy in a customer audit and previously disclosed a resolution rate above 90%. Those figures are relevant for patient access, where the main risks include sending someone to the wrong specialist, choosing an invalid appointment slot or missing a payer rule.

Hippocratic therefore has the strongest safety system and the largest body of testing. Anterior has the best independent proof for one tightly defined clinical-administrative task.

Which healthcare AI agent creates the clearest customer ROI?

Qventus has the strongest hospital-wide ROI evidence, and Assort Health has the clearest proof of new revenue at the front desk.

Qventus works on expensive assets such as operating rooms, hospital beds and clinical labor. A large nonprofit health system reported an 8.6-times annualized return, 228 additional hours of robotic operating-room capacity and 24% growth in selected surgical service lines. Another academic medical center used the platform to enable 333 extra cases, including 74 high-value surgeries.

More recent deployments have moved into coding and care gaps. A Midwestern academic medical center reported about $2.2 million in financial impact from Qventus’s malnutrition-care automation, while Boston Medical Center reported tens of thousands of labor hours saved.

Assort’s returns appear sooner and are easier to trace. The agents answer calls that staff previously missed, apply scheduling rules and place appointments directly into the EHR. More booked appointments then produce measurable revenue. Across several named practices, disclosed gains range from $120,000 in annual after-hours revenue to more than $2 million after deployment.

Tennr’s customer results focus more on throughput. Medical Service Company cut order-creation time by 90% and tripled daily output. Kilgore’s Respiratory raised order volume 5.5 times. Total Medical Supply increased patient volume by 72% without adding headcount.

Qventus wins when we value large hospital economics. Assort wins when we want the simplest connection between an AI agent and additional revenue.

If you want more recent data on this point, please see our latest healthcare AI market report.

Who can handle a large health system or payer deployment today?

Qventus has the deepest health-system implementation record, while Infinitus and Anterior have the strongest routes into large payers and life-sciences companies.

Qventus has spent more than a decade working inside hospitals. Northwestern Medicine, HonorHealth and Allina Health invested in the company as strategic partners. Other named customers include Boston Medical Center, Banner Health, OhioHealth and the University of Miami Health System. Direct investment from hospital customers usually reflects a deeper relationship than a short software pilot.

Infinitus has built an unusually strong enterprise customer base for voice automation. The company serves national payers, large pharmaceutical businesses and more than 125,000 providers. At Cencora, its agents reportedly performed work equivalent to more than 100 full-time employees and completed requests four times faster.

Anterior has the strongest new distribution channel in the payer segment. Its partnership with HealthEdge places Anterior’s clinical intelligence inside GuidingCare, a care-management platform already used by health plans. Anterior says the organizations it supports collectively cover 50 million lives. One large payer deployment handles about six million prior authorizations annually, although the company has not said that all six million are automated.

Hyro has broad health-system distribution across patient-access channels. Its customer list includes Intermountain Health, Sutter Health, Baptist Health, Tampa General Hospital and Prisma Health. Hyro’s latest research also found that advanced EHR integrations were strongly associated with higher returns, which fits its strategy of embedding agents deeply inside existing call-center systems.

Qventus is the strongest choice for a complex hospital-wide rollout. Infinitus and Anterior look especially strong when the buyer is a payer, pharmaceutical company or large healthcare administrator.

What can the healthcare AI agent leaders do that competitors cannot easily copy?

Hippocratic AI, Assort Health and Qventus have the hardest advantages to copy because each has accumulated a different kind of operating knowledge.

Hippocratic’s advantage comes from clinical conversations and safety testing. The platform has learned how patients describe symptoms, misunderstand instructions, change subjects, hesitate or reveal a problem indirectly. Its architecture uses specialized models to check different parts of a conversation and decide when a human should take over. A competitor can access the same foundation models, but it cannot quickly recreate years of reviewed healthcare conversations.

Assort owns a detailed map of specialty access rules. Its dataset covers tens of thousands of care protocols and more than a million decision pathways. These include provider preferences, appointment types, insurance restrictions and timing rules. In dermatology, for example, the system handles iPLEDGE scheduling windows and payer-specific rules after surgical procedures.

Qventus learns how individual hospitals operate. Surgeon preferences, operating-room release patterns, case duration, bed availability and discharge behavior differ from one system to another. Once Qventus becomes part of those workflows, replacing it requires more than installing new software. The hospital would also have to rebuild local rules and retrain teams.

Tennr is building a similar advantage around service-to-payer criteria. Its models connect clinical documents, insurance policies and referral requirements to determine what is missing and where a patient should go next.

Large platforms remain the biggest threat. Epic, Oracle, Salesforce, ServiceNow and major AI model providers already control technology budgets or essential healthcare systems. The startup leaders need to stay far enough ahead in workflow quality that buyers continue choosing a specialist instead of an acceptable feature bundled into an existing contract.

Which healthcare AI agent startup has the strongest momentum now?

Assort Health has the strongest momentum now, with Hippocratic AI in second place and Anterior and Hyro making the most interesting recent moves behind them.

Assort has combined fast revenue growth, a new billion-dollar valuation, broader product coverage and expansion into larger health systems. The company’s latest platform now connects inbound calls, outbound outreach, referrals, intake, payments and staff tools through one patient history. That is a meaningful shift from its original position as a voice scheduling vendor.

Hippocratic has continued expanding across several fronts. Polaris 5.0 added new clinical skills, the company acquired Grove AI to deepen its life-sciences business, and new partnerships extended its reach into health systems and consulting-led implementations. Hippocratic currently looks more like a broad healthcare agent company than it did a year ago.

Anterior is widening its ambition beyond prior authorization. Its platform now targets payment integrity, risk adjustment, care management and population health. The HealthEdge agreement could turn a small number of direct payer deployments into much broader distribution.

Hyro has also added a fresh layer to its product. Care Intelligence turns millions of agent conversations into data about access problems, call demand and unresolved patient needs. That gives Hyro something more valuable than call deflection: a way to show health systems where their access system is breaking.

Notable deserves a mention here too. A 350-bed community hospital now runs 50 Notable workflows in production, with 13,000 staff hours returned and prior-authorization time reduced by 80%. That is stronger evidence of platform breadth than Notable was publishing a year ago.

Assort is moving fastest commercially. Hippocratic is broadening fastest strategically.

If you want more recent data on this point, please see our latest healthcare AI market report.

Who leads each healthcare AI agent niche?

Healthcare AI agents still have several specialist leaders, so the best vendor depends heavily on the workflow.

Hippocratic is strongest when the agent needs to hold a clinically informed conversation with a patient. Assort is ahead when the problem starts with a phone call, appointment or referral at a specialty practice. Qventus is the clearest leader when a hospital wants to manage beds, operating rooms and care operations.

Tennr has built the strongest referral-orchestration product. Infinitus is especially credible for repetitive calls between providers, payers, pharmacies and life-sciences companies. Anterior leads payer clinical review. Hyro stands out in health-system call centers and digital access. Notable covers the widest range of general administrative workflows, although it lacks the same visible lead in one narrow segment.

Healthcare AI agent niche	Current leader	Why it leads
Patient-facing clinical conversations	Hippocratic AI	Broad clinical coverage, large production use and the strongest disclosed safety program
Specialty scheduling and patient access	Assort Health	Deep specialty rules, direct EHR actions and rapid commercial growth
Hospital operations	Qventus	Long implementation history and measurable gains in capacity, labor and revenue
Referral and patient orchestration	Tennr	Strong document models, payer-rule mapping and high customer throughput
Payer and pharmaceutical calls	Infinitus Systems	Large-enterprise customer base and substantial voice-agent usage
Payer clinical review	Anterior	KLAS-verified accuracy and production deployments inside major health plans
Health-system call centers	Hyro	Broad channel coverage, deep integrations and dozens of health-system customers
General administrative automation	Notable	Agents spanning access, prior authorization, revenue cycle and care operations

How much can we trust the healthcare AI agent numbers?

The order is credible, but the exact gaps remain less certain because most startups define usage and ROI in their own way.

Hippocratic reports patient interactions and real patient calls. Assort reports patient interactions. Infinitus uses patients served and conversation minutes. Tennr talks about monthly care pathways. Hyro sometimes reports patients reached. These measures describe different units, so calculating market share from them would create false precision.

Financial disclosure is even thinner. Assort gives us a growth multiple without the underlying revenue. Tennr has also disclosed its growth rate without publishing current revenue. Hippocratic, Qventus, Infinitus, Hyro, Notable and Anterior keep their revenue private.

Customer case studies provide more useful evidence when they name the buyer, give a before-and-after result and explain the workflow. Qventus’s operating-room capacity, Assort’s appointment revenue, Tennr’s referral throughput and Notable’s staff hours all meet that standard. The studies were still selected by the vendors, so weak deployments are unlikely to appear.

Independent evidence remains rare. Anterior’s KLAS-verified accuracy is the strongest example. Hyro commissioned an independent survey of nearly 400 healthcare leaders, although the study measured industry outcomes rather than Hyro’s own product performance. Hippocratic has published extensive testing, with company researchers involved in much of the work.

We have enough evidence to identify the leaders. We have much less evidence for a precise score separating first from second, or fifth from sixth.

Which healthcare AI agent startups are actually ahead?

Hippocratic AI is ahead overall today, Assort Health is the only close challenger, and Qventus leads the next group.

Hippocratic takes first place because it combines clinical depth, broad use-case coverage, large-scale deployment, strong safety work and access to providers, payers and pharmaceutical companies. The company is already selling a platform rather than one isolated workflow.

Assort ranks second and has the best chance of taking the lead. Its agents are producing measurable revenue for customers, its own business is growing very quickly, and its product has spread across the patient journey. Assort still trails Hippocratic in clinical breadth and safety evidence.

Qventus takes third place. It has fewer headline-grabbing voice interactions, but its agents control expensive hospital workflows and produce clear financial returns. Tennr follows in fourth because its referral and payer-rule engine is scaling quickly across a large, messy part of healthcare.

Anterior ranks fifth. It is smaller than the leaders, yet its independent accuracy evidence, payer distribution and access to organizations covering tens of millions of lives give it considerable upside. Infinitus ranks sixth with a strong customer base and proven voice automation, followed by Hyro and Notable.

The ranking could change quickly. Assort would move into first place by extending its growth into larger health systems and publishing strong safety evidence for more complex workflows. Hippocratic would pull further ahead by releasing revenue, retention and independently validated production outcomes. Anterior could enter the top four if HealthEdge turns its clinical-review technology into large transaction volumes across several payer workflows.

Rank	Startup	Why it is ahead
1	Hippocratic AI	Best overall combination of clinical breadth, deployment maturity, safety testing and strategic reach
2	Assort Health	Fastest commercial growth, major patient-access scale and clear customer revenue gains
3	Qventus	Deepest hospital-operations record and the strongest evidence of system-wide ROI
4	Tennr	Leading referral-orchestration platform with rapid customer throughput and strong workflow depth
5	Anterior	Best payer clinical-review agent, supported by independent accuracy evidence and major distribution potential
6	Infinitus Systems	Strong enterprise penetration and proven automation of difficult healthcare calls
7	Hyro	Broad health-system reach, deep access integrations and a promising new analytics layer
8	Notable	Wide administrative coverage and credible production results, with less visible recent commercial acceleration

If you want more recent data on this point, please see our latest healthcare AI market report.

::: ​​

Who is the author of this content?

NEW MARKET PITCH TEAM

We track new markets so founders and investors can move faster

We build living "market pitch" documents for emerging markets: AI, synthetic biology, new proteins, and more. Instead of outdated PDFs or hallucinated LLM answers, our clients get a clean, visual, always-updated view of what's really happening: key players, deals, regulations, and signals that matter. Learn more about us.